NCT07021859View on ClinicalTrials.gov

Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide

NARecruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

June 27, 2025

Primary Completion Date

June 1, 2026

Study Completion Date

December 30, 2026

Conditions
Migraine AuraMigraine With Aura
Interventions
DRUG

Calcitonin-gene related peptide (CGRP)

The participants will receive a continuous intravenous infusion of 1.5 μg/min of CGRP over 60 minutes.

DRUG

Placebo

The participants will receive a continuous intravenous infusion of 60 mL of placebo (isotonic saline) over 60 minutes.

Trial Locations (1)

2600

RECRUITING

Rigshospitalet Glostrup, Glostrup Municipality

All Listed Sponsors
lead

Danish Headache Center

OTHER

NCT07021859 - Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide | Biotech Hunter | Biotech Hunter